mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |